EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Iopanoic acid rapidly restores euthyroidism in refractory thyrotoxicosis pre-thyroidectomy: a retrospective study

Christine Newman, Muhammed Saqlain, Isra Ahmed Mohammed, Daniel Bell, Greta Lyons, Piyush Jani, Brian Fish, Diana Wood, Denise Tapa, David Halsall, Susan Oddy, Krishna Chatterjee iD und 2 weitere

European Thyroid Journal · 01.03.2026 · 15 (2)

DOI: 10.1530/etj-25-0350 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Thyroid Journal, online erschienen am 25.02.2026. Verfasst von Christine Newman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Diabetes and Endocrine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Hauptthemen laut MEDLINE: Thyrotoxicosis, Thyroidectomy, Iopanoic Acid, Contrast Media. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIHR Cambridge Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Restoration of euthyroidism in patients with thyrotoxicosis prior to thyroidectomy is recommended to decrease perioperative morbidity and thyroid storm risk. This is challenging when conventional anti-thyroid medication is contraindicated or ineffective. Iopanoic acid (IOPA), an iodinated contrast medium formerly used as an oral cholecystographic agent, may facilitate treatment of thyrotoxicosis, but limited manufacture precludes its use in the UK. We investigated the effectiveness and safety of IOPA for optimizing thyroid status in treatment-resistant thyrotoxicosis prior to thyroidectomy at a referral centre.

Methods

With prior permission of our Drug and Therapeutics Committee, we sourced laboratory-grade (>98% pure) IOPA and administered this orally to control ongoing, severe thyrotoxicosis prior to thyroidectomy in 12 patients with inadequate response to standard therapies. Underlying aetiologies included Graves’ disease, amiodarone-induced thyrotoxicosis, toxic multinodular goitre and resistance to thyroid hormone beta. Medical case notes were reviewed retrospectively to analyse clinical and biochemical outcomes.

Results

All patients exhibited a decline and normalization/near-normalization of free T3 (FT3) levels (mean 55% decrease, SEM 4.5%), with minimal changes in FT4 levels. Eleven patients proceeded to uneventful thyroidectomy, and IOPA was well tolerated with no directly attributable side effects.

Conclusion

IOPA is a safe and effective agent for controlling biochemical thyrotoxicosis in preparation for thyroidectomy, including disease refractory to conventional medication. Highly pure, laboratory-grade iopanoic acid that is approved for human use is now available in the UK; consideration should be given to more widespread use for emergency treatment of life-threatening hyperthyroidism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyrotoxicosisThyroidectomyIopanoic AcidContrast MediaHumansRetrospective StudiesFemaleMaleMiddle AgedAdultTreatment OutcomeGraves DiseaseAgedTriiodothyronine

Stichwörter der Autor:innen

Graves’ diseaseamiodaroneiopanoic acidthyroidectomythyrotoxicosis

Substanzen

Iopanoic AcidContrast MediaTriiodothyronine

Autor:innen und Institutionen

  • Wolfson Diabetes and Endocrine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Pharmacy Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Department of Ear Nose and Throat Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Department of Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

ORCID-Profile: Krishna Chatterjee, Nadia Schoenmakers, Carla Moran

Förderung

  • Wellcome Trust
  • NIHR Cambridge Biomedical Research Centre

Zitieren

APA

Newman, C., Saqlain, M., Mohammed, I. A., Bell, D., Lyons, G., Jani, P., Fish, B., Wood, D., Tapa, D., Halsall, D., Oddy, S., Chatterjee, K., Schoenmakers, N., & Moran, C. (2026). Iopanoic acid rapidly restores euthyroidism in refractory thyrotoxicosis pre-thyroidectomy: a retrospective study. European Thyroid Journal, 15(2). https://doi.org/10.1530/etj-25-0350

Vancouver

Newman C, Saqlain M, Mohammed IA, Bell D, Lyons G, Jani P, et al. Iopanoic acid rapidly restores euthyroidism in refractory thyrotoxicosis pre-thyroidectomy: a retrospective study. European Thyroid Journal. 2026;15(2). doi:10.1530/etj-25-0350

BibTeX
@article{Newman2026,
  author = {Newman, Christine and Saqlain, Muhammed and Mohammed, Isra Ahmed and Bell, Daniel and Lyons, Greta and Jani, Piyush and Fish, Brian and Wood, Diana and Tapa, Denise and Halsall, David and Oddy, Susan and Chatterjee, Krishna and Schoenmakers, Nadia and Moran, Carla},
  title = {Iopanoic acid rapidly restores euthyroidism in refractory thyrotoxicosis pre-thyroidectomy: a retrospective study},
  journal = {European Thyroid Journal},
  year = {2026},
  volume = {15},
  number = {2},
  doi = {10.1530/etj-25-0350}
}
Kostenlos starten →